(Yicai Global) Oct. 12 -- The Gold AQ Blood Glucose Monitoring System Sinocare Inc. [SHE:300298] produces has won approval from the US Food and Drug Administration (FDA) under Section 510(K) of the Food, Drug and Cosmetic Act -- which regulates medical devices -- indicating that the product qualifies for sale in the US.

Sinocare's US subsidiary Sinocare Meditech Inc. recently received the relevant notification documents from FDA, the company announced yesterday.

This move will boost sales of its products in global markets, the company crowed.